DCF — UNIVERSITY MEDICAL CENTER
Enterprise Value: $-339.7M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-339.7M
Enterprise Value
$-129.7M
PV of Cash Flows
$-209.9M
PV of Terminal Value
$-338.1M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $874.5M | $-9.0M | -1.0% | $-46.0M | $-41.8M |
| Year 2 | $900.7M | $-0.3M | -0.0% | $-38.4M | $-31.7M |
| Year 3 | $927.7M | $9.0M | 1.0% | $-30.3M | $-22.7M |
| Year 4 | $955.5M | $14.0M | 1.0% | $-26.4M | $-18.0M |
| Year 5 | $984.2M | $16.9M | 2.0% | $-24.7M | $-15.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-339.7M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$849.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.015307263180225655
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5